US Patent No: 7,785,631

Number of patents in Portfolio can not be more than 2000

Solid dose delivery vehicle and methods of making same

Stats

ALSO PUBLISHED AS: 20050276846
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

The present invention encompasses a solid dose delivery vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and shaped for penetrating the epidermis. The delivery vehicle further comprises a stabilizing polyol glass loaded with the bioactive material and capable of releasing the bioactive material in situ. The present invention further includes methods of making and using the solid dose delivery vehicle of the invention.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
QUADRANT DRUG DELIVERY LIMITEDNOTTINGHAM62

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blair, Julian Nottingham, GB 19 444
Colaco, Camilo Trumpington, GB2 33 602
Kampinga, Jaap Groningen, NL 24 397
Roser, Bruce J Balsham, GB2 31 913

Cited Art

Patent Info (Count) # Cites Year
 
NOVARTIS PHARMA AG (67)
5,098,893 Storage of materials 99 1990
5,458,135 Method and device for delivering aerosolized medicaments 192 1992
5,607,915 Pulmonary delivery of active fragments of parathyroid hormone 57 1994
5,928,469 Process for storage of materials 24 1994
5,785,049 Method and apparatus for dispersion of dry powder medicaments 114 1994
5,994,314 Compositions and methods for nucleic acid delivery to the lung 37 1995
6,582,728 Spray drying of macromolecules to produce inhaleable dry powders 64 1995
5,775,320 Method and device for delivering aerosolized medicaments 94 1995
5,780,014 Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin 52 1996
5,814,607 Pulmonary delivery of active fragments of parathyroid hormone 60 1996
6,071,428 Stable compositions 41 1996
6,051,256 Dispersible macromolecule compositions and methods for their preparation and use 76 1996
6,685,967 Methods and compositions for pulmonary delivery of insulin 25 1996
6,258,341 Stable glassy state powder formulations 61 1996
5,997,848 Methods and compositions for pulmonary delivery of insulin 109 1997
6,231,851 Methods and compositions for the dry powder formulation of interferons 48 1997
6,187,344 Powdered pharmaceutical formulations having improved dispersibility 45 1997
6,309,671 Stable glassy state powder formulations 35 1997
6,019,968 Dispersible antibody compositions and methods for their preparation and use 84 1997
6,138,668 Method and device for delivering aerosolized medicaments 58 1997
6,077,543 Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients 76 1997
6,089,228 Apparatus and methods for dispersing dry powder medicaments 61 1998
6,136,346 Powdered pharmaceutical formulations having improved dispersibility 57 1998
5,993,783 Method and apparatus for pulmonary administration of dry powder .alpha.1-antitrypsin 46 1998
6,080,721 Pulmonary delivery of active fragments of parathyroid hormone 34 1998
6,655,379 Aerosolized active agent delivery 34 1999
RE37872 Storage of materials 14 1999
6,257,233 Dry powder dispersing apparatus and methods for their use 53 1999
6,426,210 Storage of materials 20 1999
6,165,463 Dispersible antibody compositions and methods for their preparation and use 63 1999
6,303,582 Compositions and methods for nucleic acid delivery to the lung 29 1999
6,509,006 Devices compositions and methods for the pulmonary delivery of aerosolized medicaments 23 1999
6,123,936 Methods and compositions for the dry powder formulation of interferons 55 1999
6,372,258 Methods of spray-drying a drug and a hydrophobic amino acid 37 1999
6,423,344 Dispersible macromolecule compositions and methods for their preparation and use 42 2000
6,479,049 Methods and compositions for the dry powder formulation of interferons 19 2000
6,365,190 Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients 30 2000
6,514,496 Dispersible antibody compositions and methods for their preparation and use 13 2000
6,681,767 Method and device for delivering aerosolized medicaments 24 2000
6,503,411 Stable compositions 13 2000
6,543,448 Apparatus and methods for dispersing dry powder medicaments 33 2000
6,673,335 Compositions and methods for the pulmonary delivery of aerosolized medicaments 16 2000
6,358,530 Powdered pharmaceutical formulations having improved dispersibility 23 2000
6,630,169 Particulate delivery systems and methods of use 26 2000
6,546,929 Dry powder dispersing apparatus and methods for their use 14 2001
6,589,560 Stable glassy state powder formulations 17 2001
2002/0071,871 Apparatus and process to produce particles having a narrow size distribution and particles made thereby 10 2001
6,569,406 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation 18 2001
RE38385 Storage of materials 15 2001
2002/0132,787 Compositions and methods for nucleic acid delivery to the lung 10 2001
6,592,904 Dispersible macromolecule compositions and methods for their preparation and use 31 2001
2002/0127,188 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid 12 2002
6,572,893 Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients 23 2002
6,797,258 Compositions and methods for the pulmonary delivery of aerosolized macromolecules 19 2002
6,825,031 Storage of materials 13 2002
2002/0192,164 Methods and compositions for the pulmonary delivery insulin 10 2002
6,737,045 Methods and compositions for the pulmonary delivery insulin 22 2002
2003/0035,778 Methods and compositions for the dry powder formulation of interferon 9 2002
2003/0072,718 Methods and compositions for the dry powder formulation of interferons 11 2002
2003/0086,877 Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments 13 2002
2003/0092,666 Compositions and methods for nucleic acid delivery to the lung 9 2002
2003/0198,601 Compositions and methods for the pulmonary delivery of aerosolized medicaments 13 2002
2003/0185,765 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid 10 2003
2003/0203,036 Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients 16 2003
2003/0215,512 Stable glassy state powder formulations 12 2003
2004/0096,401 Methods and compositions for the pulmonary delivery of insulin 9 2003
2005/0186,143 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation 10 2004
 
QUADRANT DRUG DELIVERY LIMITED (9)
5,518,709 Preparation of diagnostic agents 75 1993
5,621,094 Method of preserving agarose gel structure during dehydration by adding a non-reducing glycoside of a straight-chain sugar alcohol 27 1994
5,955,448 Method for stabilization of biological substances during drying and subsequent storage and compositions thereof 70 1994
5,957,848 Preparation of further diagnostic agents 49 1995
6,344,182 Preparation of diagnostic agents by spray drying 45 1995
6,468,782 Methods of preserving prokaryotic cells and compositions obtained thereby 17 1997
6,586,006 Solid delivery systems for controlled release of molecules incorporated therein and methods of making same 30 2001
6,811,792 Solid dose delivery vehicle and methods of making same 114 2002
7,056,495 Solid dose delivery vehicle and methods of making same 82 2003
 
AMGEN INC. (5)
5,284,656 Pulmonary administration of granulocyte colony stimulating factor 134 1992
5,354,934 Pulmonary administration of erythropoietin 86 1993
6,565,841 Pulmonary administration of granulocyte colony stimulating factor 21 1993
5,580,856 Formulation of a reconstituted protein, and method and kit for the production thereof 90 1994
5,567,433 Liposome preparation and material encapsulation method 17 1995
 
NOVARTIS AG (5)
5,342,625 Pharmaceutical compositions comprising cyclosporins 175 1992
5,578,567 Nasal pharmaceutical composition 31 1993
6,518,239 Dry powder compositions having improved dispersivity 65 2000
2003/0113,273 Methods and compositions for pulmonary delivery of insulin 9 2002
2004/0096,400 Methods and compositions for the pulmonary delivery insulin 9 2003
 
GLAXO GROUP LIMITED (4)
4,627,432 Devices for administering medicaments to patients 247 1983
4,866,051 Micronised beclomethasone dipropionate monohydrate compositions and methods of use 44 1985
4,811,731 Devices for administering medicaments to patients 184 1986
4,778,054 Pack for administering medicaments to patients 101 1986
 
LIPOSOME TECHNOLOGY, INC. (4)
4,895,719 Method and apparatus for administering dehydrated liposomes by inhalation 270 1987
5,043,165 Novel liposome composition for sustained release of steroidal drugs 45 1988
5,049,389 Novel liposome composition for the treatment of interstitial lung diseases 154 1989
5,192,528 Corticosteroid inhalation treatment method 52 1989
 
NOVO NORDISK HEALTHCARE A/G (4)
5,547,696 Pharmaceutical formulation 22 1994
5,631,225 Pharmaceutical formulation 21 1994
5,654,278 Composition and method comprising growth hormone and leucine 21 1995
5,849,700 Pharmaceutical formulation 32 1995
 
QUADRANT HOLDINGS CAMBRIDGE LIMITED (4)
5,891,873 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease 13 1997
6,034,080 Use of Maillard reaction inhibitors for the treatment of amyloidosis-based disease 15 1998
6,313,102 Method for stabilization of biological substances during drying and subsequent storage and compositions thereof 31 1999
6,331,310 Solid dose delivery vehicle and methods of making same 44 2000
 
TEIJIN LIMITED (4)
4,294,829 Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof 67 1980
4,613,500 Powdery pharmaceutical composition for nasal administration 180 1984
5,626,871 Preparation for intratracheobronchial administration 19 1994
5,972,388 Ultrafine particle power for inhalation and method for production thereof 26 1997
 
THE JOHNS HOPKINS UNIVERSITY (4)
4,790,305 Medication delivery system 129 1986
4,926,852 Medication delivery system phase one 141 1988
5,027,806 Medication delivery system phase two 80 1990
5,320,094 Method of administering insulin 96 1992
 
APTAR RADOLFZELL GMBH (3)
6,179,164 Dispenser for media, particularly powder 18 1999
6,484,715 Media dispenser 20 1999
6,367,473 Medium dispenser 24 1999
 
ASTRAZENECA AB (3)
4,907,583 Device in powder inhalators 131 1988
5,506,203 Systemic administration of a therapeutic preparation 123 1994
6,794,357 Compositions for inhalation 8 1996
 
FISONS LIMITED (3)
4,249,526 Inhalation device 47 1979
6,123,924 Pressurized aerosol inhalation compositions 27 1995
6,138,673 Inhalation device and method 18 1997
 
FUISZ TECHNOLOGIES LTD. (3)
4,873,085 Spun fibrous cosmetic and method of use 86 1988
5,380,473 Process for making shearform matrix 47 1992
5,567,439 Delivery of controlled-release systems(s) 71 1994
 
KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (3)
4,812,444 Dehydration of hydrous matter using anhydrous glycosylfructose 31 1986
4,849,225 Process to prepare solid products containing oil-soluble substance 18 1987
4,824,938 Water-soluble dry solid containing proteinaceous bioactive substance 51 1987
 
QDOSE LIMITED (3)
6,290,991 Solid dose delivery vehicle and methods of making same 51 1994
5,993,805 Spray-dried microparticles and their use as therapeutic vehicles 155 1995
6,565,871 Solid dose delivery vehicle and methods of making same 34 2001
 
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (3)
4,818,542 Porous microspheres for drug delivery and methods for making same 218 1986
4,741,872 Preparation of biodegradable microspheres useful as carriers for macromolecules 143 1986
5,160,745 Biodegradable microspheres as a carrier for macromolecules 128 1990
 
ALKERMES CONTROLLED THERAPEUTICS, INC. (2)
6,569,458 Process for producing small particles of biologically active molecules 23 1993
5,674,534 Composition for sustained release of non-aggregated erythropoietin 35 1995
 
ARADIGM CORPORATION (2)
5,364,838 Method of administration of insulin 164 1993
5,672,581 Method of administration of insulin 53 1994
 
ASAHI KASEI KOGYO KABUSHIKI KAISHA (2)
4,656,250 [Nle.sup.8, Nle.sup.18, Tyr.sup.34 or Phe.sup.34 ]-h-PTH peptide derivatives 38 1984
5,563,122 Stabilized parathyroid hormone composition 14 1994
 
ASTRA AKTIEBOLAG (2)
5,642,728 System for dispensing pharmaceutically active compounds 76 1996
5,952,008 Processes for preparing compositions for inhalation 84 1997
 
BIOJECT INC. (2)
4,790,824 Non-invasive hypodermic injection device 159 1987
5,312,335 Needleless hypodermic injection device 115 1991
 
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (2)
4,865,871 Method for cryopreparing biological tissue 75 1988
5,051,261 Method for preparing a solid sustained release form of a functionally active composition 36 1990
 
BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (2)
5,200,399 Method of protecting biological materials from destructive reactions in the dry state 58 1991
5,290,765 Method of protecting biological materials from destructive reactions in the dry state 85 1992
 
BRITISH TECHNOLOGY GROUP LIMITED (2)
5,254,330 Aerosol carriers 86 1991
5,376,386 Aerosol carriers 97 1992
 
GENENTECH, INC. (2)
6,099,517 Intrapulmonary delivery of polypeptide growth factors and cytokines 20 1993
5,589,167 Excipient stabilization of polypeptides treated with organic solvents 73 1994
 
GLAXO INC. (2)
5,376,359 Method of stabilizing aerosol formulations 103 1992
5,239,993 Dosage inhalator providing optimized compound inhalation trajectory 60 1992
 
KING PHARMACEUTICALS, INC. (2)
4,590,206 Inhalation pharmaceuticals 107 1984
5,260,306 Inhalation pharmaceuticals 94 1991
 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY (2)
4,861,627 Preparation of multiwall polymeric microcapsules 159 1987
5,482,927 Controlled released microparticulate delivery system for proteins 54 1994
 
MEDEX, INC. (2)
5,186,166 Powder nebulizer apparatus and method of nebulization 75 1992
5,355,872 Low flow rate nebulizer apparatus and method of nebulization 79 1992
 
NABISCO TECHNOLOGY COMPANY (2)
4,327,076 Compressed chewable antacid tablet and method for forming same 96 1980
4,327,077 Compressed chewable antacid tablet and method for forming same 72 1981
 
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT (2)
4,889,114 Powdered pharmaceutical inhaler 87 1987
6,013,638 Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung 29 1993
 
NOVO NORDISK A/S (2)
4,946,828 Novel insulin peptides 62 1987
5,705,482 Pharmaceutical formulation 27 1995
 
QUADRANT BIORESOURCES LIMITED (2)
4,891,319 Protection of proteins and the like 153 1987
5,026,566 Dried food containing trehalose and method for preparing same 68 1989
 
RIKER LABORATORIES, INC. (2)
4,446,862 Breath actuated devices for administering powdered medicaments 89 1981
4,624,251 Apparatus for administering a nebulized substance 90 1984
 
SS PHARMACEUTICAL CO., LTD. (2)
4,684,719 .alpha.,.alpha.-trehalose fatty acid diester derivative 29 1985
4,814,436 Derivative of .alpha., .alpha.-trehalose and a process for preparing the same 23 1986
 
SYNTEX PUERTO RICO, INC. (2)
4,192,309 Inhalation device with capsule opener 30 1978
4,227,522 Inhalation device 30 1978
 
TAKEDA CHEMICAL INDUSTRIES, LTD. (2)
4,211,769 Preparations for vaginal administration 49 1978
4,659,696 Pharmaceutical composition and its nasal or vaginal use 129 1983
 
THE GENERAL HOSPITAL CORPORATION (2)
4,698,328 Method of increasing bone mass 78 1986
4,833,125 Method of increasing bone mass 85 1987
 
THE ROCKEFELLER UNIVERSITY (2)
4,758,583 Method and agents for inhibiting protein aging 87 1985
5,334,617 Amino acids useful as inhibitors of the advanced glycosylation of proteins 26 1992
 
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (2)
6,190,859 Method and kit for detection of dengue virus 13 1995
5,972,366 Drug releasing surgical implant or dressing material 63 1996
 
WARNER-LAMBERT COMPANY (2)
4,847,090 Confection product and method for making same 64 1986
5,013,557 Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same 64 1989
 
WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINICAL RESEARCH CENTRE LIMITED (2)
5,204,108 Transmucosal formulations of low molecular weight peptide drugs 120 1990
5,707,644 Small particle compositions for intranasal drug delivery 89 1994
 
WISCONSIN ALUMNI RESEARCH FOUNDATION (2)
5,580,859 Delivery of exogenous DNA sequences in a mammal 457 1994
5,512,547 Pharmaceutical composition of botulinum neurotoxin and method of preparation 66 1994
 
YAMANOUCHI PHARMACEUTICAL CO., LTD. (2)
5,026,772 Lyophilized pharmaceutical composition of neocarzinostatin derivative 16 1988
5,453,514 Pyrazole derivatives and compositions and methods of use as maillard reaction inhibitors 19 1993
 
3M INNOVATIVE PROPERTIES COMPANY (1)
5,225,183 Medicinal aerosol formulations 178 1991
 
ABBOTT LABORATORIES (1)
5,302,581 Pulmonary surfactant protein fragments 45 1992
 
ACUSPHERE, INC. (1)
5,611,344 Microencapsulated fluorinated gases for use as imaging agents 42 1996
 
ADAMS USA INC. (1)
4,997,654 Method for increasing salivation for xerostomia patients 20 1989
 
ALKERMES, INC. (1)
5,112,596 Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability 52 1990
 
ALLERGAN, INC. (1)
5,173,298 Nonaqueous fluorinated drug delivery vehicle suspensions 41 1990
 
ALMIRALL, S.A. (1)
5,881,719 Inhaler for administering medicaments from blister packs 58 1996
 
ANALYTICAL CONTROL SYSTEMS, INC. (1)
5,348,852 Diagnostic and therapeutic compositions 31 1992
 
ANDI-VENTIS LIMITED (1)
5,033,463 Multi-dose inhaler for medicaments in powder form 139 1990
 
APPLIED ENZYME TECHNOLOGY LTD. (1)
5,240,843 Enzyme stabilisation 39 1991
 
ARMSTRONG PHARMACEUTICALS, INC. (1)
5,215,079 Single dose metered dose inhaler for delivery of vaccines and other drugs 44 1992
 
BASF AKTIENGESELLSCHAFT (1)
5,326,586 Coating of drug forms 6 1992
 
BATTELLE MEMORIAL INSTITUTE (1)
5,422,384 Glass/polymer composites and methods of making 33 1992
 
BEECHAM INC. (1)
4,372,942 Candy base and liquid center hard candy made therefrom 65 1981
 
BIO-DAR LTD. (1)
4,749,575 Microencapsulated medicament in sweet matrix 115 1986
 
BIOENG, INC. (1)
5,554,382 Methods and apparatus for making liposomes 46 1993
 
BIOVAIL LABORATORIES INTERNATIONAL SRL (1)
4,855,326 Rapidly dissoluble medicinal dosage unit and method of manufacture 112 1988
 
BOEHRINGER INGELHEIM VETMEDICA, INC. (1)
5,733,555 Modified live BRSV vaccine 34 1996
 
BOEHRINGER MANNHEIM GMBH (1)
4,701,417 Control or calibration serum for lipid diagnosis 39 1985
 
BOOTS COMPANY PLC, THE (1)
5,240,712 Therapeutic agents 24 1992
 
BORDEN (UK) LIMITED (1)
5,270,048 Controlled delivery devices 20 1992
 
BRACCO RESEARCH S.A. (1)
4,888,398 Biodegradable polypeptide and the use thereof for the gradual release of drugs 20 1985
 
BRADFORD WHITE CORPORATION (1)
6,142,216 Indirect water heater 19 1997
 
BRONSON NUTRITIONALS, LLC (1)
5,571,499 Treatment of autoimmune diseases by aerosol administration of autoantigens 67 1995
 
CADBURY ADAMS USA LLC (1)
4,753,790 Sorbitol coated comestible and method of preparation 66 1986
 
CALIFORNIA BIOTECHNOLOGY INC. (1)
5,011,678 Composition and method for administration of pharmaceutically active substances 134 1989
 
CHIRON CORPORATION (1)
5,681,746 Retroviral delivery of full length factor VIII 49 1994
 
CHIRON DIAGNOSTICS CORPORATION (1)
4,883,762 Stabilized isoenzyme control products 31 1989
 
COBE LABORATORIES, INC. (1)
5,425,951 Method of reconstituting lyophilized cells 39 1991
 
COOPER LABORATORIES, INC. (1)
5,618,786 Aerosolization of protein therapeutic agent 22 1994
 
DADE BEHRING INC. (1)
4,762,857 Trehalose as stabilizer and tableting excipient 73 1987
 
DADE BEHRING MARBURG GMBH (1)
4,305,925 Latex reagent 38 1980
 
DARDIN, FRANCIS E. (1)
4,680,027 Needleless hypodermic injection device 99 1985
 
DSM N.V. (1)
5,312,909 Recombinant DNA encoding neutral trehalase 17 1991
 
E. R. SQUIBB & SONS, INC. (1)
4,830,858 Spray-drying method for preparing liposomes and products produced thereby 131 1985
 
EASTMAN KODAK COMPANY (1)
5,057,392 Low fusing temperature toner powder of cross-linked crystalline and amorphous polyester blends 90 1990
 
ECONOMICS LABORATORY, INC. (1)
4,617,272 Enzyme drying process 33 1984
 
ELAN DRUG DELIVERY LIMITED (1)
5,728,574 Viability of bacterial dried cells 15 1995
 
ELAN PHARMA INTERNATIONAL LIMITED (1)
4,952,402 Controlled release powder and process for its preparation 155 1988
 
EMISPHERE TECHNOLOGIES, INC. (1)
5,667,806 Spray drying method and apparatus 66 1995
 
EURAND INTERNATIONAL S.P.A. (1)
5,306,506 Pharmaceutical composition for rapid suspension in water 46 1992
 
FISONS PLC (1)
5,976,436 Process for production of medicament formulations 15 1997
 
FOX CHASE CANCER CENTER (1)
5,231,031 Method for assessing risk of diabetes-associated pathologic conditions and efficacy of therapies for such conditions 13 1990
 
GAINES PET FOODS CORP., A CORP. OF DE (1)
4,371,557 Maintenance of protein quality in foods containing reducing sugars 15 1981
 
GENEMEDICINE, INC. (1)
5,811,406 Dry powder formulations of polynucleotide complexes 43 1995
 
GENTEX CORPORATION (1)
6,752,893 Rimless spectacles and method for making the same 14 2001
 
HARRIS, JOAN, MIAMI BEACH, (1)
4,551,329 Oral medicament lollipop 40 1984
 
HASTINGS, DONALD H. (1)
5,017,372 Method of producing antibody-fortified dry whey 54 1988
 
HERMES FABRIK PHARMAZEUTISCHER PRAPARATE (1)
5,112,598 Vitamin A aerosol-inhalate preparations 84 1989
 
HOFFMANN-LA ROCHE INC. (1)
4,503,035 Protein purification process and product 60 1983
 
INNOVATA BIOMED LIMITED (1)
5,384,133 Pharmaceutical formulations comprising microcapsules 161 1993
 
INVERNESS MEDICAL SWITZERLAND GMBH (1)
5,120,643 Process for immunochromatography with colloidal particles 209 1987
 
ITALVACUUM DI ING. P. DEBOLINI & C. S.A.S., VIA STOPPIANA 3, 10071 BORGARO (TORINO) ITALY (1)
4,698,917 Rotary drier for drying heat-sensitive products and pharmaceuticals 14 1986
 
JOUVEINAL S.A. (1)
4,761,400 Laxative composition based on lactulose and its preparation process 18 1986
 
KEY PHARMACEUTICALS, INC. (1)
4,484,577 Drug delivery method and inhalation device therefor 142 1982
 
LIFE CELL CORPORATION (1)
5,780,295 Apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions 38 1996
 
MAQUET CRITICAL CARE AB (1)
4,819,629 Method and apparatus for delivering aerosol to the airways and/or lungs of a patient 245 1987
 
MCINTOSH; KENNETH B. (1)
4,942,544 Medication clock 86 1989
 
MERRION RESEARCH III LIMITED (1)
6,423,334 Composition and method for enhancing transport across gastrointestinal tract cell layers 14 1998
 
MIAT S.P.A. (1)
4,884,565 Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola 72 1988
 
MICRODOSE THERAPEUTX, INC. (1)
2005/0147,566 Site specific delivery of co-administered drugs via inhalation 9 2004
 
MINNESOTA MINING AND MANUFACTURING COMPANY (1)
4,326,524 Solid dose ballistic projectile 38 1980
 
MIRIS MEDICAL INCORPORATED, A CORP. OF CA (1)
5,404,871 Delivery of aerosol medications for inspiration 248 1991
 
NEKTAR THERAPEUTICS UK, LTD. (1)
5,851,453 Method and apparatus for the formation of particles 73 1996
 
NESTEC S.A. (1)
4,748,034 Preparing a heat stable aqueous solution of whey proteins 37 1986
 
NEW YORK BLOOD CENTER, INC. (1)
4,591,552 Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide 55 1982
 
NEXSTAR PHARMACEUTICALS, INC. (1)
5,089,181 Method of dehydrating vesicle preparations for long term storage 47 1989
 
NOVOZYMES A/S (1)
4,898,781 Water-soluble microcapsules 43 1987
 
NTI HOLDINGS CORP. (1)
5,387,431 Saccharide-based matrix 45 1992
 
ORTHO-MCNEIL PHARMACEUTICAL, INC. (1)
4,906,463 Transdermal drug-delivery composition 65 1988
 
OSAKA UNIVERSITY (1)
5,948,411 Stabilized live vaccine 12 1994
 
OTSUKA PHARMACEUTICAL CO., LTD. (1)
5,422,360 Maillard reaction inhibitor 18 1993
 
PAFRA LIMITED (1)
4,863,865 Preservation by cold storage 11 1988
 
PAUL RITZAU PARI-WERK GMBH (1)
5,309,900 Atomizer particularly for use in devices for inhalation therapy 79 1991
 
PFIZER INC. (1)
5,175,179 Method for treating hypertension 5 1991
 
PH&T S.R.L. (1)
4,995,385 Inhaler with regular complete emptying of the capsule 83 1990
 
POPULATION COUNCIL, INC., THE (1)
4,244,949 Manufacture of long term contraceptive implant 32 1978
 
PPG INDUSTRIES OHIO, INC. (1)
5,098,955 Powder coating composition low Tg and high Tg polymers with acid groups 40 1990
 
PRINCESS RING LLC (1)
5,287,850 Timing and velocity controlled powered pharmaceutical inhaler 44 1991
 
PROMO PACK SA (1)
5,207,217 Multiple single-dose inhaler for medicaments in powder form 83 1991
 
QUADRANT BIORESOURCES LIMITED, CAMBRIDGE RESEARCH LABORATORIES, 181A HUNTINGDON ROAD, CAMBRIDGE, CB3 ODJ, GREAT BRITAIN (1)
5,149,653 Preservation of viruses 71 1989
 
QUADRANT TECHNOLOGIES LIMITED (1)
6,060,069 Pulmonary delivery of pharmaceuticals 22 1998
 
R.I.PH. RECHERCHE INFORMATIQUE ET PHARMACIE (S.A.R.L.) (1)
4,985,252 Medication, dietetic product and hygienic product in the form of a powered composition obtained by adsorption of active ingredients on a rapidly dissolving sugar and process for obtaining said composition 18 1988
 
RESEARCH DEVELOPMENT FOUNDATION (1)
5,049,388 Small particle aerosol liposome and liposome-drug combinations for medical use 163 1989
 
ROCHE PALO ALTO LLC (1)
5,202,333 Tricyclic 5-HT.sub.3 receptor antagonists 30 1991
 
ROQUETTE FRERES (1)
4,423,086 Process for hard coating with sorbitol and products obtained thereby 45 1981
 
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (1)
5,042,975 Iontotherapeutic device and process and iontotherapeutic unit dose 142 1987
 
SAINT-GOBAIN CALMAR INC. (1)
6,591,832 Dry powder dispenser 12 2002
 
SANOFI (1)
5,488,062 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof 15 1994
 
SANOFI-SYNTHELABO (1)
5,466,701 Saccharin derivative proteolytic enzyme inhibitors 14 1994
 
SCHERING CORPORATION (1)
4,847,079 Biologically stable interferon compositions comprising thimerosal 44 1987
 
SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (1)
4,963,359 Non-cariogenic confections 21 1989
 
SCIOS NOVA INC. (1)
5,006,343 Pulmonary administration of pharmaceutically active substances 118 1988
 
SEPRACOR INC. (1)
5,337,740 Inhalation devices 50 1991
 
SHIMADZU CORPORATION (1)
6,649,911 Method of selecting ions in an ion storage device 24 2002
 
SIERRA BIOTECHNOLOGY COMPANY, L.C. (1)
4,984,158 Metered dose inhaler biofeedback training and evaluation system 260 1988
 
SOMOVA S.P.A. (1)
5,048,514 Inhaler for medicaments contained in capsules 70 1990
 
SONORAN DESERT CHEMICALS LIMITED LIABILITY COMPANY (1)
5,093,316 Treatment of inflammation 44 1990
 
SORIN BIOMEDICA S.P.A. (1)
5,139,016 Process and device for aerosol generation for pulmonary ventilation scintigraphy 63 1989
 
SRI INTERNATIONAL (1)
5,354,562 Process for preparing micronized polypeptide drugs 106 1993
 
STANDARD TELEPHONES AND CABLES PUBLIC LIMITED COMPANY (1)
4,793,997 Controlled delivery device 27 1987
 
STC PLC (1)
4,407,786 Glass composition 30 1981
 
SUPRATEK PHARMA INC. (1)
5,656,611 Polynucleotide compositions 49 1994
 
SYNGENTA LIMITED (1)
5,366,734 Continuous release pharmaceutical compositions 45 1991
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5,575,987 Method of producing sustained-release microcapsules 54 1995
 
TANABE SEIYAKU CO., LTD. (1)
4,462,982 Microcapsules and method of preparing same 41 1982
 
THE IMMUNE RESPONSE CORPORATION (1)
6,737,066 HIV immunogenic compositions and methods 31 2000
 
THE PENN STATE RESEARCH FOUNDATION (1)
5,855,913 Particles incorporating surfactants for pulmonary drug delivery 215 1997
 
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1)
5,679,647 Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides 101 1994
 
THE REGENTS OF THE UNIVERSITY OF MICHIGAN (1)
5,240,846 Gene therapy vector for cystic fibrosis 169 1990
 
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (1)
5,591,453 Incorporation of biologically active molecules into bioactive glasses 81 1995
 
TOYO JOZO KABUSHIKI KAISHA (1)
5,059,587 Physiologically active peptide composition for nasal administration 27 1988
 
TRUDELL MEDICAL LIMITED (1)
4,534,343 Metered dose inhaler 122 1984
 
UNISIA JECS CORPORATION (1)
5,989,217 Medicine administering device for nasal cavities 18 1997
 
UNIVERSAL PRESERVATION TECHNOLOGIES, INC. (1)
5,766,520 Preservation by foam formation 34 1997
 
UNIVERSITY OF AUCKLAND (1)
4,677,975 Method of dispensing and/or a dispenser 295 1985
 
VIRGINIA COMMONWEALTH UNIVERSITY (1)
5,182,097 Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content 78 1991
 
VSESOJUZNY NAUCHNO-ISSLEDOVATELSKY INSTITUT MEDITSINSKIKH POLIMEROV (1)
4,620,847 Device for administering powdered substances 39 1984
 
WALES COLLEGE OF CARDIFF (1)
5,230,884 Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations 106 1992
 
WYETH (1)
5,403,861 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers 41 1992
 
YEN, RICHARD C.K. (1)
5,069,936 Manufacturing protein microspheres 154 1989
 
ZYMOGENETICS, INC. (1)
4,599,311 Glycolytic promotersfor regulated protein expression: protease inhibitor 59 1982
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (16)
4,253,468 Nebulizer attachment 87 1978
4,338,931 Device for the quick inhalation of drugs in powder form by humans suffering from asthma 81 1980
4,588,744 Method of forming an aqueous solution of 3-3-Bis(p-hydroxyphenyl)-phthalide 36 1981
4,452,239 Medical nebulizing apparatus 81 1981
4,721,709 Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions 47 1984
4,743,554 Recombinant DNA expression vector encoding for foot and mouth disease virus proteins 9 1985
4,713,249 Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof 103 1985
4,739,754 Suction resistant inhalator 73 1986
4,762,719 Powder filled cough product 53 1986
5,035,237 Devices for administering medicaments to patients 119 1988
4,988,683 New pharmaceutical compositions for the buccal tract and process for their preparation 13 1989
5,113,855 Powder inhaler 109 1990
5,349,947 Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow 128 1993
6,303,581 Methods and kits for removing, treating, or preventing lice with driable pedicul ostatic agents 19 2001
2003/0113,900 Methods of preserving prokaryotic cells and compositions obtained thereby 9 2002
2004/0219,206 Solid dose delivery vehicle and methods of making same 10 2004

Patent Citation Ranking

Forward Cites

  • No Forward Cites to Display

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 28, 2014
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 28, 2018
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 28, 2022
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00